Literature DB >> 14515004

Poor lipid control in type-2 diabetics with and without ischemic heart disease.

Daad H Akbar1, Aish A Al-Gamdi, Nariman A Hejazi.   

Abstract

To determine the frequency of type-2 diabetics who have target lipoprotein blood levels, to study these levels in patients with ischemic heart disease and cardiovascular disease risk factors, and to study the possible causes of poor control, we reviewed hyperlipdemic type-2 diabetics who were on regular follow up to the medical outpatient clinic of King Abdulaziz University Hospital from January 2000 to January 2001. A total of 202 patients were studied with mean age of 60 yr and equal male to female ratio. The mean duration of diabetes was 10 yr and it was 7 yr for hyperlipidemia. The mean level of LDL was 3.15 mmol/L and it was 1.0 mmol/L and 2.47 mmol/L for HDL and TG, respectively. Only 31% of patients had LDL < 2.6 mmol/L, 28% had HDL > 1.1 mmol/L, and 37% had TG < 1.7 mmol/L. No significant difference was found in the frequency of target level of LDL in patients with IHD and those without; 26% vs 34% (0.4). Similarly, no difference was found in those with hypertension, obesity, and patients with family history of IHD compared to those without these risk factors; 30%, 26%, 16% vs 34%, 36%, 33% (p = 0.2, 0.1, 0.4, respectively). Males were found to have a higher frequency of target LDL level compared to females; 38% vs 25% (p = 0.04). Poor diet restriction was found in 90% of patients' with poor control, lack of patients' knowledge in 62%, 70% have financial reasons, 86% of patients on multiple medications, and in 16% the treating physician took no proper action. In conclusion, a low frequency of type-2 diabetics have target levels of lipoproteins. Diabetics with IHD and CVD risk factors also have poor lipid control. Poor control was associated with poor diet compliance and use of multiple medications. Proper management and control of this disease is needed among elderly patients.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14515004     DOI: 10.1385/ENDO:21:3:217

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  25 in total

Review 1.  Seminars in Medicine of the Beth Israel Hospital, Boston. Non-insulin-dependent diabetes mellitus - a genetically programmed failure of the beta cell to compensate for insulin resistance.

Authors:  K S Polonsky; J Sturis; G I Bell
Journal:  N Engl J Med       Date:  1996-03-21       Impact factor: 91.245

2.  Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS: 23)

Authors:  R C Turner; H Millns; H A Neil; I M Stratton; S E Manley; D R Matthews; R R Holman
Journal:  BMJ       Date:  1998-03-14

3.  Health care and health status and outcomes for patients with type 2 diabetes.

Authors:  M I Harris
Journal:  Diabetes Care       Date:  2000-06       Impact factor: 19.112

4.  The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators.

Authors:  F M Sacks; M A Pfeffer; L A Moye; J L Rouleau; J D Rutherford; T G Cole; L Brown; J W Warnica; J M Arnold; C C Wun; B R Davis; E Braunwald
Journal:  N Engl J Med       Date:  1996-10-03       Impact factor: 91.245

Review 5.  Improving the adverse cardiovascular prognosis of type 2 diabetes.

Authors:  J H O'Keefe; J M Miles; W H Harris; R M Moe; B D McCallister
Journal:  Mayo Clin Proc       Date:  1999-02       Impact factor: 7.616

Review 6.  Is hypertriglyceridaemia an independent risk factor for coronary heart disease? The epidemiological evidence.

Authors:  M Miller
Journal:  Eur Heart J       Date:  1998-07       Impact factor: 29.983

7.  Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels.

Authors: 
Journal:  N Engl J Med       Date:  1998-11-05       Impact factor: 91.245

8.  Sex differential in ischemic heart disease mortality in diabetics: a prospective population-based study.

Authors:  E Barrett-Connor; D L Wingard
Journal:  Am J Epidemiol       Date:  1983-10       Impact factor: 4.897

9.  Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study.

Authors:  J R Downs; M Clearfield; S Weis; E Whitney; D R Shapiro; P A Beere; A Langendorfer; E A Stein; W Kruyer; A M Gotto
Journal:  JAMA       Date:  1998-05-27       Impact factor: 56.272

10.  Cholesterol lowering with simvastatin improves prognosis of diabetic patients with coronary heart disease. A subgroup analysis of the Scandinavian Simvastatin Survival Study (4S)

Authors:  K Pyŏrälä; T R Pedersen; J Kjekshus; O Faergeman; A G Olsson; G Thorgeirsson
Journal:  Diabetes Care       Date:  1997-04       Impact factor: 19.112

View more
  6 in total

1.  Predictors of poor glycaemic control in older patients with type 2 diabetes mellitus.

Authors:  Shariff-Ghazali Sazlina; Ismail Mastura; Ai Theng Cheong; Adam Bujang Mohamad; Haniff Jamaiyah; Ping Yein Lee; Syed Abdul Rahman Syed Alwi; Boon How Chew
Journal:  Singapore Med J       Date:  2015-05       Impact factor: 1.858

2.  Evaluation of glycemic control in patients with type 2 diabetes mellitus in Chinese communities: a cross-sectional study.

Authors:  Shan Shan; Liubao Gu; Qinglin Lou; Xiaojun Ouyang; Yun Yu; Haidi Wu; Rongwen Bian
Journal:  Clin Exp Med       Date:  2015-12-22       Impact factor: 3.984

3.  PPARγ-induced cardiolipotoxicity in mice is ameliorated by PPARα deficiency despite increases in fatty acid oxidation.

Authors:  Ni-Huiping Son; Shuiqing Yu; Joseph Tuinei; Kotaro Arai; Hiroko Hamai; Shunichi Homma; Gerald I Shulman; E Dale Abel; Ira J Goldberg
Journal:  J Clin Invest       Date:  2010-09-13       Impact factor: 14.808

Review 4.  Quality of type 2 diabetes management in the states of the Co-operation Council for the Arab States of the Gulf: a systematic review.

Authors:  Layla Alhyas; Ailsa McKay; Anjali Balasanthiran; Azeem Majeed
Journal:  PLoS One       Date:  2011-08-04       Impact factor: 3.240

5.  High Fat Diet Upregulates Fatty Acid Oxidation and Ketogenesis via Intervention of PPAR-γ.

Authors:  Kunal Sikder; Sanket Kumar Shukla; Neel Patel; Harpreet Singh; Khadija Rafiq
Journal:  Cell Physiol Biochem       Date:  2018-07-26

6.  The achievement of comprehensive control targets among type 2 diabetes mellitus patients of different ages.

Authors:  Yun Yu; Kaipeng Xie; Qinglin Lou; Hui Xia; Dan Wu; Lingli Dai; Cuining Hu; Kunlin Wang; Shan Shan; Yun Hu; Wei Tang
Journal:  Aging (Albany NY)       Date:  2020-07-22       Impact factor: 5.682

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.